Completed NA INTERVENTIONAL 3-arm NCT02505451

Myocardial Regional Function by Dobutamine Stress Echocardiography in the Metabolic Syndrome and Type 2 Diabetes

Comprehensive Analysis of Regional Myocardial Function in Response to Dobutamine Stress in Metabolic Syndrome and Type 2 Diabetic Patients. Effect of Cardiac Adiposity, Inflammation and Hyperglycaemia

Sponsor: University of Avignon

Conditions Diabetes-related Complications

Interventions dobutamine

Updated 8 times since 2017 Last updated: Jan 17, 2019 Started: Jul 31, 2015 Primary completion: Jan 31, 2018 Completion: Jan 31, 2019

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Diabetes-related Complications, this trial is completed. The trial is conducted by University of Avignon and has accumulated 8 data snapshots since 2015. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Feb 2019 — Jan 2021 [monthly]

Completed NA

Status: Recruiting → Completed
Jun 2018 — Feb 2019 [monthly]

Recruiting NA

▶ Show 3 earlier versions

Mar 2018 — Jun 2018 [monthly]

Recruiting NA
Dec 2017 — Mar 2018 [monthly]

Recruiting NA
Jan 2017 — Dec 2017 [monthly]

Recruiting NA

First recorded

Jul 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University of Avignon

Data source: University of Avignon

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Avignon, France